Anzeige
Mehr »
Login
Mittwoch, 29.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
205 Leser
Artikel bewerten:
(1)

The Business Reseach Company: Healthcare Interoperability Solutions Market Growth Rate Rises Towards 14% Through 2026

Finanznachrichten News

The Business Research Company's healthcare interoperability solutions market research report expands on key drivers, trends, and growth opportunities in the market.

LONDON, July 6, 2022 /PRNewswire/ -- The healthcare interoperability solutions market consists of the sale of interoperability solutions by entities (organizations, sole traders, and partnerships) used in the healthcare industry. Interoperability refers to the exchange of healthcare information between two or more systems. Healthcare interoperability enables seamless data sharing across healthcare organizations with the patient's consent. Electronic health records (EHRs) along with health information exchange (HIE) services must be optimized and adopted by every healthcare firm to implement interoperability functionalities. Interoperability achievement depends on five key components namely, privacy and security, standards, rules of engagement, adoption & optimization, and financial & clinical incentives.

tbrc_logo

The global healthcare interoperability solutions market size is expected to grow from $3.4 billion in 2021 to $3.85 billion in 2022 at a compound annual growth rate (CAGR) of 13.4%. The global healthcare interoperability solution market size is expected to grow to $6.44 billion in 2026 at a CAGR of 13.7%.

Request a free sample of the Healthcare Interoperability Solutions Market Report

Interoperability Solutions Market Segmentation

1) By Type: Software Solutions, Services

2) By Software Solution: Electronic Health Record (EHR) Interoperability Solutions, Lab System Interoperability Solutions, Imaging System Interoperability Solutions, Healthcare Information Exchange Interoperability Solutions, Enterprise Interoperability Solutions, Others

3) By Level of Interoperability: Foundational Interoperability, Structural Interoperability, Semantic Interoperability

4) By End-User: Healthcare Providers, Healthcare Payers, Pharmacies

Healthcare Interoperability Solutions Market Growth Drivers

The government initiatives to enhance patient care and safety are expected to propel the growth of the healthcare interoperability solutions market over the coming years. The shortcoming in the healthcare systems is arising due to increasing demand in public with the COVID-19 pandemic. Government authorities across the globe such as the Canter for Medicare & Medicaid Services (CMS) have set the goal of increasing healthcare availability by implementing advanced technologies to better treat the patients. For instance, in May 2020, CMS Interoperability and Patient Access Final Rule is published by CMS. The rule is promoting the policies that enable advanced interoperability and access to health information for all stakeholders.

Healthcare Interoperability Solutions Industry

North America was the largest region in the healthcare interoperability market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the global healthcare interoperability solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

See more on the Healthcare Interoperability Solutions Market Report

Check out similar market reports:

Healthcare EDI Global Market Report 2022 - By Component (Software, Hardware, Services), By Transaction (Claim Management, Healthcare Supply Chain, Other Transactions), By Mode of Delivery (Mobile, VAN, Web & Cloud-based, Point-to-point), By End-User (Healthcare Provider, Payer, Pharmacies, Other End-Users) - Market Size, Trends, And Global Forecast 2022-2026

Healthcare Cloud Computing Global Market Report 2022 - By Deployment Model (Private Cloud, Hybrid Cloud, Public Cloud), By End-User (Healthcare Providers, Healthcare Payers), By Pricing Model (Pay-as-you-go, Spot Pricing), By Service Model (Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS)), By Application (Clinical Information System, Non-Clinical Information System) - Market Size, Trends, And Global Forecast 2022-2026

Healthcare Analytics Market - By Type Of Technology (Descriptive analytics, Predictive analytics, Prescriptive analytics), By Application (Clinical data analytics, Administrative & Operational, Financial analytics, Others), By Component (Hardware, Software, Services), And By Region, Opportunities And Strategies - Global Forecast To 2022

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has strategy enablement specialists in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.